Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Cancer Genetics Inc.

TRADE

NASDAQ: CGIXHealthcare / Medical Laboratories & Research / USA
0.93+0.01+1.09%Vol 260 2711Y Perf -75.59%
Jul 20th, 2018 15:22
BID0.92 ASK0.95
Open0.93 Previous Close0.92
Pre-Market- After-Trading-
 - -%  - -%
Target Price
4.50 
Analyst Rating
Moderate Buy 2.00
Potencial %
383.87 
Finscreener Ranking
★★★★+ —    -
Insiders Trans % 3/6/12M
-/-/100 
Value Ranking
     36.66
Insiders Value % 3/6/12M
-/-/100 
Growth Ranking
★+     41.85
Insiders Shares Cnt. % 3/6/12M
-/-/100 
Income Ranking
 —    -
Market Cap (mil)26 
Earnings Rating
Price Range Ratio 52wk %
3.51 
Earnings Date
13th Aug 2018

Today's Price Range

0.900.95

 

52wk Range

0.823.95

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
-6.06%
3 Months
-15.45%
6 Months
-51.05%
1 Year
-75.59%
3 Years
-91.88%
5 Years
-91.44%

Quotes

Name / TickerPriceChg.Chg.%
CGIX0.930.01001.09
AAPL191.44-0.4400-0.23
GOOG1 184.91-2.0500-0.17
MSFT106.271.87001.79
XOM81.40-0.6100-0.74
WFC56.410.08000.14
JNJ125.85-0.0900-0.07
FB209.941.85000.89
GE13.12-0.6100-4.44
JPM111.281.39001.26
...

TickerPriceChg.%52 Week High
CTAS203.575.11204.27
PM84.314.22120.00
VFC92.944.1593.51
HON153.133.79165.13
SWK144.233.28176.62
PDCO23.642.8743.20
DOV80.242.7188.11
STI70.842.6473.37
ADS233.082.59278.33
NUE66.252.4470.48
KSU111.052.40114.91
IDXX248.142.19248.65
COF97.231.95106.50
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 0.70
Current Ratio 0.90
Long Term Debt to Total Capital 0.03
Total Debt to Equity 0.52
Interest Coverage -6.80
Leverage Ratio 2.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin36.50
EBIT Margin-49.30
EBITDA Margin-42.20
Pre-tax Profit Margin-127.80
Profit Margin-54.85
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 1.21
PS Ratios 1.05
Price to Cash Flow -
Price to Free Cash Flow -1.90
Cash Flow Per Share -0.69
Price to Tangible Book-15.41
Book Value per Share0.72
Enterprise Value (in ths.)30 765
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-62.27
ROE last 12 Months -71.18
Return on Assets (5Y Avg) -37.65
ROA last 12 Months -32.61
Return on Capital (5Y Avg) -46.14
ROC last 12 Months -48.32
Return on invested Capital Q -12.45
Return on invested Capital Y-55.43
Assets Turnover0.50
Receivables Turnover1.90
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)23 218
Revenue per Share 0.84
Revenue Growth 3 Years 19.30
Revenue Growth 5 Years 41.56
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2018--0.16-
Q04 2017--0.35-
Q03 2017-0.13-0.16-23.08
Q02 2017-0.16-0.160.00
Q01 2017-0.18-0.1138.89
Q04 2016-0.22-0.1531.82
Q03 2016-0.28-0.2317.86
Q02 2016-0.33-0.2815.15
Earnings Per EndEstimateRevision %Trend
6/2018 QR-0.13-225.00Negative
9/2018 QR-0.12-700.00Negative
12/2018 FY-0.46-170.59Negative
12/2019 FY-0.16--
Next Report Date13th Aug 2018
Estimated EPS Next Report-0.13
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume260 271
Shares Outstanding (in ths.)27 750
Trades Count248
Dollar Volume233 754
Avg. Volume407 130
Avg. Weekly Volume113 562
Avg. Monthly Volume82 706
Avg. Quarterly Volume156 948

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

56%44%

Bearish Bullish

68%32%

Bearish Bullish

70%30%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (50.00 %)
2 (50.00 %)
2 (50.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (50.00 %)
2 (50.00 %)
2 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.00
Moderate Buy
2.00
Moderate Buy
2.00

There are no comments yet.

News

x